Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386592109> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W4386592109 abstract "Patients are increasingly undergoing bilateral total shoulder arthroplasty (TSA). At present, it is unknown whether success after the 1st TSA is predictive of success after contralateral TSA. We aimed to determine whether exceeding clinically important thresholds of success after primary TSA predicts similar outcomes for subsequent contralateral TSA.We performed a retrospective review of a prospectively-collected shoulder arthroplasty database for patients undergoing bilateral primary anatomic (aTSA) or reverse (rTSA) total shoulder arthroplasty since January 2000 with preoperative and 2- or 3-year clinical follow-up. Our primary outcome was whether exceeding clinically important thresholds in the American Shoulder and Elbow Surgeons (ASES) score for the 1st TSA was predictive of similar success of the contralateral TSA; thresholds for the ASES score were adopted from prior literature and included the minimal clinically important difference (MCID), the substantial clinical benefit (SCB), 30% of maximal possible improvement (30%MPI), and the patient acceptable symptomatic state (PASS). The PASS is defined as the highest level of symptom beyond which patients consider themselves well, which may be a better indicator of a patient's quality of life. To determine whether exceeding clinically important thresholds was independently predictive of similar success after 2nd contralateral TSA, we performed multivariable logistic regression adjusted for age at 2nd surgery, sex, BMI, and type of 1st and 2nd TSA.Of the 134 patients identified that underwent bilateral shoulder arthroplasty, 65 (49%) had bilateral rTSAs, 45 (34%) had bilateral aTSAs, 21 (16%) underwent aTSA/rTSA, and 3 (2%) underwent rTSA/aTSA. On multivariable logistic regression, exceeding clinically important thresholds after 1st TSA was not associated with greater odds of achieving thresholds after 2nd TSA when success was evaluated by the MCID, SCB, and 30%MPI. In contrast, exceeding the PASS after 1st TSA was associated with 5.9-times greater odds (95% CI = 2.5-14.4, P<0.001) of exceeding the PASS after 2nd TSA. Overall, patients that exceeded the PASS after 1st TSA exceeded the PASS after 2nd TSA at a higher rate (71% vs. 29%, P<0.001); this difference persisted when stratified by type of prosthesis for 1st and 2nd TSA.Patients that achieve the ASES score PASS after 1st TSA have greater odds of achieving the PASS for the contralateral shoulder regardless of prostheses type." @default.
- W4386592109 created "2023-09-12" @default.
- W4386592109 creator A5005687839 @default.
- W4386592109 creator A5012673474 @default.
- W4386592109 creator A5033207279 @default.
- W4386592109 creator A5044992117 @default.
- W4386592109 creator A5045000539 @default.
- W4386592109 creator A5066762791 @default.
- W4386592109 creator A5070717549 @default.
- W4386592109 creator A5077374736 @default.
- W4386592109 creator A5086588393 @default.
- W4386592109 creator A5088866052 @default.
- W4386592109 date "2023-09-01" @default.
- W4386592109 modified "2023-09-29" @default.
- W4386592109 title "Does Achieving Clinically-Important Thresholds After First Shoulder Arthroplasty Predict Similar Outcomes of the Contralateral Shoulder?" @default.
- W4386592109 doi "https://doi.org/10.1016/j.jse.2023.08.004" @default.
- W4386592109 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37690587" @default.
- W4386592109 hasPublicationYear "2023" @default.
- W4386592109 type Work @default.
- W4386592109 citedByCount "0" @default.
- W4386592109 crossrefType "journal-article" @default.
- W4386592109 hasAuthorship W4386592109A5005687839 @default.
- W4386592109 hasAuthorship W4386592109A5012673474 @default.
- W4386592109 hasAuthorship W4386592109A5033207279 @default.
- W4386592109 hasAuthorship W4386592109A5044992117 @default.
- W4386592109 hasAuthorship W4386592109A5045000539 @default.
- W4386592109 hasAuthorship W4386592109A5066762791 @default.
- W4386592109 hasAuthorship W4386592109A5070717549 @default.
- W4386592109 hasAuthorship W4386592109A5077374736 @default.
- W4386592109 hasAuthorship W4386592109A5086588393 @default.
- W4386592109 hasAuthorship W4386592109A5088866052 @default.
- W4386592109 hasConcept C111278954 @default.
- W4386592109 hasConcept C126322002 @default.
- W4386592109 hasConcept C141071460 @default.
- W4386592109 hasConcept C151956035 @default.
- W4386592109 hasConcept C167135981 @default.
- W4386592109 hasConcept C168563851 @default.
- W4386592109 hasConcept C2778336525 @default.
- W4386592109 hasConcept C2781184374 @default.
- W4386592109 hasConcept C71924100 @default.
- W4386592109 hasConceptScore W4386592109C111278954 @default.
- W4386592109 hasConceptScore W4386592109C126322002 @default.
- W4386592109 hasConceptScore W4386592109C141071460 @default.
- W4386592109 hasConceptScore W4386592109C151956035 @default.
- W4386592109 hasConceptScore W4386592109C167135981 @default.
- W4386592109 hasConceptScore W4386592109C168563851 @default.
- W4386592109 hasConceptScore W4386592109C2778336525 @default.
- W4386592109 hasConceptScore W4386592109C2781184374 @default.
- W4386592109 hasConceptScore W4386592109C71924100 @default.
- W4386592109 hasLocation W43865921091 @default.
- W4386592109 hasLocation W43865921092 @default.
- W4386592109 hasOpenAccess W4386592109 @default.
- W4386592109 hasPrimaryLocation W43865921091 @default.
- W4386592109 hasRelatedWork W1586374228 @default.
- W4386592109 hasRelatedWork W2003938723 @default.
- W4386592109 hasRelatedWork W2047967234 @default.
- W4386592109 hasRelatedWork W2118496982 @default.
- W4386592109 hasRelatedWork W2364998975 @default.
- W4386592109 hasRelatedWork W2369162477 @default.
- W4386592109 hasRelatedWork W2391044264 @default.
- W4386592109 hasRelatedWork W2439875401 @default.
- W4386592109 hasRelatedWork W4238867864 @default.
- W4386592109 hasRelatedWork W2525756941 @default.
- W4386592109 isParatext "false" @default.
- W4386592109 isRetracted "false" @default.
- W4386592109 workType "article" @default.